Effects of baclofen on reserpine-induced vacuous chewing movements in mice

Brain Research Bulletin

Volumn 68, Issue 6, 2006, Pages 436-441

  Castro, Juliana P M V ^a   Frussa Filho, Roberto ^a   Fukushiro, Daniela F ^a   Silva, Regina H ^a   Medrano, Wladimir A ^a   Ribeiro, Rosana De A ^a   Abílio, Vanessa C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Baclofen; GABA; Mice; Parkinsonism; Reserpine; Tardive Dyskinesia

Indexed keywords

BACLOFEN; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; MALE; MASTICATION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACUOUS CHEWING MOVEMENT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BACLOFEN; BRAIN; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MASTICATION; MICE; NEURAL INHIBITION; RECEPTORS, GABA-B; RESERPINE; SYNAPTIC TRANSMISSION;

EID: 31744451917     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2005.09.019     Document Type: Article

References (56)

1. V.C. Abílio, C.C.S. Araujo, M. Bergamo, P.R.V. Calvente, V. D'Almeida, R. de A. Ribeiro, and R. Frussa-Filho Vitamin E attenuates reserpine-induced oral dyskinesia and striatal gssg/gsh ratio enhancement in rats Prog. Neuro-Psychopharmacol. Biol. Psychiat. 27 2003 109 114
2. V.C. Abílio, R.H. Silva, R.C. Carvalho, C. Grassl, M.B. Calzavara, S. Registro, V. D'Almeida, R. de A. Ribeiro, and R. Frussa-Filho Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia Neuropharmacology 47 2004 263 272
3. V.C. Abílio, J.A.R. Vera-Jr, L.S.M. Ferreira, C.R.M. Duarte, R.C. Carvalho, C. Grassl, C.R. Martins, D. Torres-Leite, M. Bignotto, S. Tufik, R. de A. Ribeiro, and R. Frussa-Filho Effects of melatonin on orofacial movements in rats Psychopharmacology 161 2002 340 347
4. A.O. Andreassen, and H.A. Jørgensen Neurotoxicity associated with neuroleptic-induced oral dyskinesia in rats Prog. Neurobiol. 61 2000 525 541
5. N.P. Araujo, V.C. Abílio, R.H. Silva, R.C. Pereira, R.C. Carvalho, C. Gonzalez, R.G. Bellot, J.P.M.V. Castro, D.F. Fukushiro, M.S.D. Rodrigues, C.C. Chinen, and R. Frussa-Filho Effects of topiramate on oral dyskinesia induced by reserpine Brain Res. Bull. 64 2005 331 337
6. P. Baskin, G. Gianutsos, and J.D. Salamone Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuos jaw movements and enhance striatal muscarinic receptor binding Pharmacol. Biochem. Behav. 49 1994 437 442
7. P. Baskin, and J. Salamone Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine Pharmacol. Biochem. Behav. 46 1993 793 797
8. E. Brouillet, F. Conde, M.F. Beal, and P. Hantraye Replicating Huntington's disease phenotype in experimental animals Prog. Neurobiol. 59 1999 427 468
9. M.E. Burger, A. Alves, L. Callegari, F.R. Athayde, C.W. Nogueira, G. Zeni, and J.B. Rocha Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum Prog. Neuro-Psychopharmacol. Biol. Psychiat. 27 2003 135 140
10. P.R.V. Calvente, C.C.S. Araujo, M. Bergamo, V.C. Abílio, V. D'Almeida, R. de A. Ribeiro, and R. Frussa-Filho The motochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats Prog. Neuro-Psychopharmacol. Biol. Psychiat. 26 2002 1 5
11. B.B. Carlson, S.P. Behrstock, A. Tobin, and J.D. Salamone Brain implantations of engineered GABA-releasing cells supress tremor in an animal model of Parkinsonism Neuroscience 119 2003 927 932
12. R.C. Carvalho, R.H. Silva, V.C. Abílio, P.N. Barbosa, and R. Frussa-Filho Antydiskinetic effects of risperidone on animal models of tardive dyskinesia in mice Brain. Res. Bull. 60 2003 115 124
13. S.L. Cassady, G.K. Thaker, and C.A. Tamminga GABAergic treatments for tardive dyskinesia R. Yassa P.V. Nair D.P. Jeste Neuroleptic-induced Movements Disorders 1997 Cambridge University Press New York 454 469
14. P.B. Collins, C.L.E. Broeckkamp, P. Jenner, and C.D. Marsden Electromyographic differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat Psychopharmacology 112 1993 428 436
15. A.M. Donaire, and D. Gil-Saladie Progressive primary aphasia associated with corticobasal degeneration Rev. Neurol. 32 2001 1051 1054
16. R.R. Faria, V.C. Abílio, C. Grassl, C.C. Chinen, L.T. Ribeiro, J.P.M.V. Castro, D.F. Fukushiro, M.S. Dutra-Rodrigues, P.H. Zanier-Gomes, S. Registro, R.C. Carvalho, V. D'Almeida, R.H. Silva, R. de A. Ribeiro, and R. Frussa-Filho Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity Neuropharmacology 48 2005 993 1001
17. H.C. Fibiger, and K.G. Lloyd Neurobiological substrates of tardive dyskinesia: the GABA hypothesis Trends Neurosci. 7 1984 462 464
18. M. Finn, A. Jassen, P. Baskin, and J.D. Salamone Tremulous characteristics of the vacuos jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletios Pharmacol. Biochem. Behav. 57 1/2 1997 243 249
19. M. Finn, A.J. Mayorga, A. Conlan, and J.D. Salamone Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats Neuroscience 80 2 1997 535 544
20. R. Frussa-Filho, and J. Palermo-Neto Effects of single and long-term metoclopramide administration on open-field and stereotyped behavior of rats Eur. J. Pharmacol. 149 1988 323 329
21. J. Gerlach, T. Rye, and P. Kristjansen Effect of baclofen on tardive dyskinesia Psychopharmacol. Berlin 56 1978 145 151
22. L.M. Gunne, U. Anderson, U. Bondesson, and P. Johanson Spontaneous chewing movements in rats during acute and chronic antipsychotic administration Phamacol. Biochem. Behav. 25 1986 897 901
23. L.M. Gunne, J.E. Haggstrom, and B. Sjokvist Association with persistent neuroleptic-induced dyskinesia of regional changes in the brain GABA synthesis Nature 309 1984 347 349
24. K. Ishiwari, S. Mingote, M. Correa, J.T. Trevitt, B.B. Carlson, and J.D. Salamone The GABA uptake inhibitor β-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis J. Neurosci. Meth. 140 2004 39 46
25. G.A. Jicha, and J.D. Salamone Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms J. Neurosci. 11 1991 3822 3829
26. A.E. Kelley, V.P. Bakshi, J.M. Delphis, and C.G. Lang Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity Psychopharmacology 99 1989 542 549
27. A.D. Levy, R.E. See, E.D. Levin, and G.D. Ellison Neuroleptic-induced oral movements in rats: methodological issues Life Sci. 41 1987 1499 1506
28. A.J. Mayorga, D.L. Carriero, M.S. Cousins, G. Gianutsos, and J.D. Salamone Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects Pharmacol. Biochem. Behav. 56 1997 273 279
29. J.O. McNamara Drugs effective in the therapy of the epilepsies J.G. Hardman L.E. Limbird A.G. Gilman The Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw-Hill New York 521 547
30. I.J. Mitchell, S. Lawson, B. Moser, S.M. Laidlaw, A.J. Cooper, G. Walkinshaw, and C.M. Waters Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat Neuroscience 63 1994 1 5
31. J.L. Neisewander, E. Castañeda, and D.A. Davis Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia Psychopharmacology 116 1994 79 84
32. J.L. Neisewander, E. Castañeda, D.A. Davis, H.J. Elson, and A.N. Sussman Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia Eur. J. Pharmacol. 305 1996 13 21
33. J.L. Neisewander, I. Lucki, and P. Mcgonigle Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats J. Pharmacol. Exp. Ther. 257 1991 850 860
34. J.L. Neisewander, I. Lucki, and P. Mcgonigle Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment Brain Res. 558 1991 27 35
35. V. Paille, P. Brachet, and P. Damier Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease Neuroreport 15 2004 561 564
36. M.F. Peixoto, V.C. Abílio, R.H. Silva, and R. Frussa-Filho Effects of valproic acid on an animal model of tardive dyskinesia Behav. Brain Res. 142 2003 229 233
37. M.F. Peixoto, N.P. Araujo, R.H. Silva, J.P.M.V. Castro, D.F. Fukushiro, R.R. Faria, P.H. Zanier-Gomes, W.A. Medrano, R. Frussa-Filho, and V.C. Abílio Effects of gabaergic drugs on reserpine-induced oral dyskinesia Behav. Brain Res. 160 2005 51 59
38. V. Raghavendra, P.S. Naidu, and S.K. Kulkarni Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors Brain Res. 904 2001 149 152
39. N.M.J. Rupniak, P. Jenner, and C.D. Marsden Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats Psychopharmacology 79 1983 226 230
40. N.M.J. Rupniak, P. Jenner, and C.D. Marsden Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats Psychopharmacology 85 1985 71 79
41. O.S. Sachdev The current status of tardive dyskinesia Aust. NZ J. Psychiatry 34 2000 355 369
42. J.D. Salamone, and P. Baskin Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible mode of parkinsonian tremor Pharmacol. Biochem. Behav. 53 1996 179 183
43. J.D. Salamone, C.J. Johnson, L.D. McCullough, and R.E. Steinpreis Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat Psychopharmacology 102 1990 529 534
44. J.D. Salamone, M.D. Lalies, S.L. Channel, and S.D. Iversen Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat Psychopharmacology 88 1986 467 471
45. J.D. Salamone, A.J. Mayorga, J.T. Trevitt, M.S. Cousins, A. Conlan, and A. Nawab Tremulous jaw movements in rats: a model of parkinsonian tremor Prog. Neurobiol. 56 1998 591 611
46. T. Sasaki, J.L. Kennedy, and J.N. Nobrega Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements Synapse 25 1997 73 79
47. R.P. Shank, J.F. Gardocki, and J.L. Vaught Topiramate: preclinnical evaluation of a structurally novel anticonvulsant Epilepsia 35 1994 450 460
48. R.E. Steinpreis, P. Baskin, and J.D. Salamone Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine Psychofarmacology 111 1993 99 105
49. B.R. Stewart, P. Jenner, and C.D. Marsden The pharmacological characterization of pilocarpine-induced chewing in the rat Psychopharmacology 97 1988 228 234
50. B.R. Stewart, S. Rose, P. Jenner, and C.D. Marsden Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT Eur. J. Pharmacol. 142 1987 173 176
51. G.K. Thaker, A.J. Nguyen, and C.A. Tamminga Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction Biol. Psychiatry 1 1988 49 59
52. G.K. Thaker, C.A. Tamminga, L.D. Alphs, J. Lafferman, T.N. Ferraro, and T.A. Hare Brain gamma-aminobutyric acid abnormality in tardive dyskinesia: reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment Arch. Gen. Psychiatry 44 1987 522 529
53. J.T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn, and J.D. Salamone Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function Psychopharmacology 132 1997 74 81
54. H.S. White, S.D. Brown, G.A. Skeen, H.H. Wolf, and R.E. Twyman The anticonvulsivant topiramate displays a unique ability to potentiate GABA-evoked chloride currents Epilepsia 36 1997 S39 S40
55. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Res. 28 1997 167 179
56. S. Wolfarth, and K. Ossowska Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia? Prog. Neuro-Psychopharmacol. Biol. Psychiat. 13 1989 799 840